Discovery of potent and selective Bcl-2 inhibitors with acyl sulfonamide skeleton-Reference-Cited by-同舟云学术

Discovery of potent and selective Bcl-2 inhibitors with acyl sulfonamide skeleton

Published:2021-10 Issue: Volume:47 Page:116350
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Wang Bin,Feng Weiwei,Wang Jinan,Dong Yuanzhen,Liu Yanlong,Yao Yiyan,Zhang Jianqing,Shi Wei,Liu Limin,Zhang Hongying,He Xiangyi,Chang Xiayun,Wang Xiaojin,Xu Hongjiang,Liu Fei,Feng Jun

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference33 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Targeting apoptosis in cancer therapy;Carneiro;Nat Rev Clin Oncol,2020

3. Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance;Kapoor;Cell Death Dis,2020

4. Emerging connectivity of programmed cell death pathways and its physiological implications;Bedoui;Nat Rev Mol Cell Biol,2020

5. The Bcl2 family: regulators of the cellular life-or-death switch;Cory;Nat Rev Cancer,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Scenario of Pyridine/Quinoline-Sulfonamide Hybrids with Anticancer Potential (A Review);Russian Journal of General Chemistry;2024-04

2. PROTACs in the Management of Prostate Cancer;Molecules;2023-04-25

3. N-Acylsulfonamide: a valuable moiety to design new sulfa drug analogues;RSC Medicinal Chemistry;2023

4. Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents;Frontiers in Chemistry;2022-07-25

5. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021);Archiv der Pharmazie;2022-04-06